Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Pre-positioning of COVID-19 drugs

A promising COVID-19 drug may be imported into Canada before it receives a Canadian market authorization. This early importation and placement in Canadian facilities is referred to as “pre-positioning.” It facilitates the immediate distribution of the drug upon authorization, making it available to Canadians as early as possible.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19 : Prépositionnement des drogues contre la COVID-19
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-06-14 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["COVID-19", "pandémie", "médicament COVID-19", "modification", "Règlement sur les aliments et drogues", "médicaments", "fabricants", "présentation", "avis de conformité", "prépositionnement des médicaments COVID-19"], "en": ["COVID-19", "pandemic", "COVID-19 drug", "amendement", "Food and Drug Regulations", "drugs", "manufacturers", "submission", "notice of compliance", "pre-positioning of COVID-19 drugs"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source